AlleyCorp in Q1: Valar Atomics and the Future of Nuclear Energy

In 2005, the U.S. generated roughly twice as much electricity as China. Today, those numbers are reversed. In fact, China now generates more electricity than the US, EU, and India combined.

In May of last year, the Trump administration issued a series of executive actions aimed at jumpstarting our energy program, specifically in nuclear innovation. Through a pilot program within the Department of Energy, the aim was to push startups to have at least three nuclear reactors reach criticality by July 4, 2026. One of the companies leading that charge — Valar Atomics (an AlleyCorp portfolio company) — is just a couple of months from accomplishing that goal.

Founded by Isaiah Taylor (whose great grandfather just so happened to be a nuclear physicist on the Manhattan Project), we first invested in Valar Atomics at a $20M pre-money valuation. Valar Atomics is now worth a reported $2 billion, following their latest funding round last month and their announcement last November, becoming the first nuclear startup in history to split an atom.

Just think about that: 100+ nuclear startups that came before it. $10+ billion in funding. And not one had ever split an atom of uranium.

What’s different about Valar is how they’ve approached the problem. Instead of starting with years of theoretical R&D, they began by building a supply chain — sourcing existing components and assembling a system that was designed to be repeatable. The long-term goal is to build a network of small, modular reactors that can deliver reliable power beyond the grid — to data centers, military bases, and remote industrial sites — eventually scaling to produce the world’s energy.

You can’t help but admire that type of ambition.

While there’s still a long road ahead, we love backing a generational vision like Valar’s — one that could reinvent nuclear power and reshape the global energy landscape.

Earlier this month, Transcend Therapeutics (an AlleyCorp incubation) entered into a definitive agreement to be acquired by Otsuka Pharmaceutical for $700 million, with consideration for an additional $525 million contingent on future sales milestones.

Read more here.

AlleyCorp co-led Big Health’s $23M funding round alongside .406 Ventures with participation from CVS Health Ventures, Sandbox Industries, Gilde Healthcare, Supermoon Capital, and others.

With FDA-cleared digital treatments for insomnia and anxiety, Big Health has already helped more than 750,000 people access digital mental health care across the US and UK.

Read more from STAT News.

AlleyCorp led PraxisPro’s $6M Seed Round with additional investors Flybridge, South Loop Ventures, and Zeal Capital Partners also joining the round.

Founded by a former pharma sales rep, PraxisPro leverages AI agents and small language models to offer a purpose-built training platform specifically designed for life sciences.

Read more from TechCrunch.

With brands and retailers needing a way to access unrealized growth in international markets, in Q1 we launched Crossterra — a unified platform to help brands launch, operate, and scale across the world’s fastest growing economies.

As e-commerce demand accelerates in China, India, SE Asia, LATAM, and MENA, Crossterra (an AlleyCorp incubation) brings brands everything they need to launch and run global storefronts — from truly localized customer experiences to payments, logistics, and compliance all in one operating system.

Read more here.

Ualá raised $195M in an equity funding round led by Allianz X, valuing the company at $3.2 billion.

As one of Ualá’s first investors (at a $5M valuation), we’re excited to see their continued growth in Argentina, Mexico, and Colombia, with more than 11 million customers across those markets. Nearly one in five Argentinian adults now have a Ualá account.

Read more from Bloomberg.

Rogo raised $75M in Series C funding led by Sequoia Capital, valuing the company at $750M. The round also included participation from Wells Fargo and continued support from Thrive Capital, Khosla Ventures, Tiger Global, and J.P. Morgan.

More than 25,000 financial professionals are now using Rogo daily.

Read more from Axios.

AlleyCorp participated in Chamber Cardio’s $60M Series A led by Frist Cressey Ventures. The round included additional investors: General Catalyst, American Family Ventures, Company Ventures, Optum Ventures, Healthworx Ventures, and Black Opal Ventures.

As an AlleyCorp incubation, Chamber continues to prove value-based care models can make the strongest impact in specialty care, helping to tackle the leading cause of death and a top driver of U.S. healthcare spending: cardiovascular disease.

Read more from Fierce Healthcare.

Read more from TechCrunch.

Validio raised $30M in Series A funding led by Plural.

Working across banking / finance, retail, supply chain, manufacturing and more, Validio has built an agentic data management platform to improve data quality and AI detection within enterprise tech stacks.

Read more from Axios.

AlleyCorp participated in Coral Care’s $13M Series A led by Haymaker Ventures, alongside FCA Ventures, Peterson Ventures, Reach Capital, Grey Matter, and others.

The funding will accelerate Coral Care’s national expansion, including newly launched markets in Dallas, Houston, Chicago, Philadelphia, and Pittsburgh.

Read more from MedCity News.

AlleyCorp participated in Avo’s $10M Series A led by Noro-Moseley Partners with additional investors including Las Olas Venture Capital, MedMountain Ventures, Epsilon Health, and Scrub Capital.

Through its clinical AI platform, Avo is transforming Electronic Health Records (EHRs) into intelligent systems, giving clinicians the ability to synthesize patient data, propose diagnoses and care plans, assist with orders and documentation, and surface evidence-based guidance.

Read more from Endpoints News.

30+ Years of Silicon Alley

With 2026 marking the 30th Anniversary of Silicon Alley, AlleyCorp hosted a special celebration alongside many of the people and firms who have helped build NYC’s tech ecosystem from the ground up.

The milestone included many highlights, including ringing the NYSE Closing Bell, a Times Square Billboard placement, and a 30Y “Zine” commemorating the last three decades of NYC Tech.

Deep Tech New York (DTNY)

In January, we also hosted our inaugural DTNY summit, a new community and annual gathering bringing together the world’s top innovators, researchers, and founders in deep tech.

With 400+ attendees and 25+ speakers, it’s undeniable what NYC has to offer in growing the deep tech community and pushing the boundaries of science and technology.

New York Angels Summit

In February, we co-hosted the first-ever NYC Angel’s Summit along with FirstMark, Union Square Ventures, Lerer Hippeau, and Inspired Capital. The day brought together a select group of the most active and up-and-coming angel investors throughout the city, featuring mainstage talks about iconic angels including Scott Belsky, Kate Ryder, Shan-Lyn Ma, and more.

• AlleyCorp was highlighted as a cornerstone of New York tech in this Fortune feature story celebrating 30 years of Silicon Alley.

• Kevin joined Fast Company’s “Office Hour” Podcast, speaking with editor-in-chief Brendan Vaughan about 30Y of Silicon Alley, the future of AI in healthcare, innovation in deep tech, and much more.

• General Partner Marshall Porter was featured in Business Insider’s annual roundup of startups shaping the creator economy. The article also highlighted AlleyCorp portfolio companies ShopMy and Agentio.

• General Partner Alexi Nazem moderated two mainstage talks at Cornell Tech’s Health Tech Summit and the Healthcare Financial Management Association’s Annual Summit.

• Partner Susannah Shipton was profiled by Tech:NYC in their VC Spotlight series.

• Principal Luc Ryan-Schreiber was highlighted among Business Insider’s 2026 Rising Stars of VC.

• Kevin spoke to Bloomberg about the growth of NYC’s AI and tech sector and the impact it’s having on New York real estate.

• Deep Tech investors Abe Murray and Brannon Jones launched The Long Frontier podcast, a show dedicated to the most important deep tech innovations being built right now. Each episode is a standalone deep dive into the topics that interest us most, with the first show highlighting the orbital economy of space.

• ShopMy and Glacier were each named to Fast Company’s Most Innovative Companies of 2026.

• Eyebot was included on Business Insider’s list of startups most likely to become tech’s next unicorns.

• Carmoola was highlighted among Entrepreneur UK’s Top 100 Startups.

• Barte was featured in Brazilian publication Exame, highlighting its annualized revenue of nearly 300 million Brazilian Real, doubling in size in the last seven months.

• Altana was highlighted in a Fortune feature story discussing tariffs and AI’s role in navigating global supply chains.

• Birches Health was profiled by Fierce Healthcare in a piece detailing its expanded mental health offerings for addiction behavior.

• DHNY announced its New York Digital Health 100 highlighting the region's most innovative and high-impact digital health startups. This year’s list featured 10+ AlleyCorp portfolio companies.